๐ Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
<0%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
๐
SGX Earnings Announcements for P8A
Cordlife Group Limited (P8A)
Market: SGX |
Currency: SGD
Address: AโPosh Bizhub
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It offers cord blood, cord lining, and cord tissue banking services, including processing and storage of stem cells; and various diagnostics services, such as newborn genetic screening, pediatric vision and ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, and newborn metabolic screening. The company also provides Moms Up, a mobile app for pregnancy and parenting resources for moms and moms-to-be. In addition, it provides medical laboratory, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.
Show more
๐ Cordlife Group Limited Historical Chart
๐งพ Recent Financial Statement Analysis
August 15, 2025
Cordlife Group Limited: Interim Financial Analysis for H1 2025 Cordlife Group Limited has released its condensed interim financial statements for the six months ended 30 June 2025. This report provides an in-depth analysis of the company's key financial metrics, performance…
March 3, 2025
Net Profit Declined: Cordlife FY2024 Financial Analysis Net Profit Declined: Cordlife FY2024 Financial Analysis Date of Report: Released on 1 March 2025 for the full financial year ended 31 December 2024 Business Description Core Operations: Cordlife Group Limited is dedicated…
November 15, 2024
Cordlife's Strategic Resumption and Financial Outlook: A Shareholder's Insight Cordlife's Strategic Resumption and Financial Outlook: A Shareholder's Insight Singapore, 14 November 2024 โ Cordlife Group Limited has announced its financial results for the nine months ending 30 September 2024, highlighting…
November 15, 2024
Cordlife's Strategic Forward Moves Amid Financial Hurdles Cordlife's Strategic Forward Moves Amid Financial Hurdles Cordlife Group Limited has announced notable financial challenges for the 9MFY2024 period, with revenue plunging by 55.1% to S\$19.3 million and a gross profit drop of…
๐ View more in SGX corporate News ๐ View more in SGX Financial statements
๐ฐ Related News & Research
Showing results matched by any of: P8A.SI, Cordlife Group Limited, Cordlife, CLGL SP, CORDLIFE GROUP LTD, CORDLIFE GROUP
August 15, 2025
Cordlife Group Limited: Interim Financial Analysis for H1 2025 Cordlife Group Limited has released its condensed interim financial statements for the six months ended 30 June 2025. This report provides an in-depth analysis of the company's key financial metrics, performance…
March 3, 2025
Net Profit Declined: Cordlife FY2024 Financial Analysis Net Profit Declined: Cordlife FY2024 Financial Analysis Date of Report: Released on 1 March 2025 for the full financial year ended 31 December 2024 Business Description Core Operations: Cordlife Group Limited is dedicated…
November 15, 2024
Cordlife's Strategic Resumption and Financial Outlook: A Shareholder's Insight Cordlife's Strategic Resumption and Financial Outlook: A Shareholder's Insight Singapore, 14 November 2024 โ Cordlife Group Limited has announced its financial results for the nine months ending 30 September 2024, highlighting…
November 15, 2024
Cordlife's Strategic Forward Moves Amid Financial Hurdles Cordlife's Strategic Forward Moves Amid Financial Hurdles Cordlife Group Limited has announced notable financial challenges for the 9MFY2024 period, with revenue plunging by 55.1% to S\$19.3 million and a gross profit drop of…